Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 1
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02188134Completed

Quantifying the Attentive Behaviors of Older Adults During Over-the-counter Drug Selection

Role: collaborator

NCT00474175Phase 4Completed

Benzocaine Gel Toothache Dose-Response Study

Role: collaborator

NCT00796315Phase 1Completed

Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children

Role: collaborator

All 3 trials loaded